{"id":300,"date":"2020-01-13T03:27:37","date_gmt":"2020-01-13T03:27:37","guid":{"rendered":"http:\/\/retinacr.com\/?page_id=300"},"modified":"2020-01-13T04:03:26","modified_gmt":"2020-01-13T04:03:26","slug":"publications","status":"publish","type":"page","link":"https:\/\/retinacr.com\/en\/publications\/","title":{"rendered":"PUBLICATIONS"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Publicaciones<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  1. Wu L. The Omnipresence of Vascular Endothelial Growth Factor in Retinal Diseases. Taiwan J Ophthalmol 2019;9:213-215.<\/li>
  2. Wu L, Acon D, Wu A, Wu M. Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm? Taiwan J Ophthalmol 2019;9:216-223<\/li>
  3. Flikier S, Wu A, Wu L. Revisiting Pars Plana Vitrectomy in the Primary Treatment of Diabetic Macular Edema in the Era of Pharmacological Treatment. Taiwan J Ophthalmol 2019;9:224-232.<\/li>
  4. Chawan-Saad J, Wu M, Wu A, Wu L. Corticosteroids for Diabetic Macular Edema. Taiwan J Ophthalmol 2019;9:233-242<\/li>
  5. Sahoo NK, Govindhari V, Bedi R, Goud A, Singh R, Wu L<\/strong>, Chhablani J. Subretinal Hyperreflective Material in Central Serous Chorioretinopathy. Indian J Ophthalmol 2020;68:126-129<\/li>
  6. Viquez MV, Wu L<\/strong>. Sensitivity and Specificity of the Red Reflex in Costa Rican Newborns. Arch Soc Esp Oftalmol 2019 Dec 8. pii: S0365-6691(19)30307-7. doi: 10.1016\/j.oftal.2019.10.007. [Epub ahead of print]<\/li>
  7. Conti FF, Alezzandrini A, Rasendran C, Nakhwa C, Neves D, Queiroga FS, Chhablani J, Rocha J, Martins RP, Romero J, Wu L<\/strong>, Han M, Gurjar RK, Haq S, Lee S, Natarajan S, Ansari WH, Yoon YH, Singh RP; Global Diabetic Macular Edema Study Group. An International Comparison of Baseline Characteristics of Patients Undergoing Initiation of Anti-VEGF Therapy for DME.<\/a> Ophthalmic Surg Lasers Imaging Retina. 2019 Nov 1;50(11):e300-e310. doi: 10.3928\/23258160-20191031-18.<\/li>
  8. Singh SR, Fung AT, Fraser-Bell S, Lupidi M, Mohan S, Gabrielle PH, Zur D, Iglicki M, M L\u00f3pez-Corell P, Gallego-Pinazo R, Farinha C, Lima LH, Mansour AM, Casella AM, Wu L, Silva R, Uwaydat SH, Govindahari V, Arevalo JF, Chhablani J. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.<\/a> Br J Ophthalmol. 2019 Aug 10. pii: bjophthalmol-2019-314542. doi: 10.1136\/bjophthalmol-2019-314542. [Epub ahead of print]<\/li>
  9. Al-Khaled T, Mikhail M, Jonas KE, Wu WC, Anzures R, Amphonphruet A, Chuluunbat T, Wu L, <\/strong>Chiang MF, Campbell JP, Chan RVP. Training of Residents and Fellows in Retinopathy of Prematurity Around the World: An International Web Based Survey. J Ped Ophthalmol Strabismus 2019;<\/li>
  10. ArevaloJF, Lasave AF, Kozak I, Al Rashaed S, Al Kahtani E, Maia M, Farah ME, Cutolo C, Brito M, Osorio C, Navarro P, Wu L, Berrocal MH, Morales-Canton V, Serrano MA, Graue-Wiechers F, Sabrosa NA, Alezzandrini AA, Gallego-Pinazo R. Preoperative Intravitreal Bevacizumab for\u00a0Tractional\u00a0Retinal DetachmentSecondary to Proliferative Diabetic Retinopathy: Prospective Randomized Clinical Trial of the Pan-American Collaborative Retina Study (PACORES) Group.<\/a> Am J Ophthalmol. 2019 May 13. pii: S0002-9394(19)30227-2. doi: 10.1016\/j.ajo.2019.05.007. [Epub ahead of print]<\/li>
  11. Hanumunthadu D, van Dijk EHC, Dumpala S, Rajesh B, Jabeen A, Jabeen A, Ansari M, Mehta P, Shah S, Sarvaiya C, Meyerle C, Wu L<\/strong>, Banker A, Boon CJ, Chhablani J. Evaluation of Choroidal Layer Thickness in Central Serous Chorioretinopathy. J Ophthalmic Vis Res 2019;14:164-170.<\/li>
  12. Sastre-Iba\u00f1ez M, Martinez-Rubio C, Molina-Pallete R, Martinez-Lopez-Corell P, Wu L<\/strong>, Arevalo JF, Gallego-Pinazo R. Retinal Pigment Epithelial Tears. J Fr Ophtalmol 2019;42:63-72<\/li>
  13. Goncalves MB, Alves BQ, Moura R, Magalhaes O Jr, Maia A, Belfort R Jr, de Avila MP, Zas M, Saravia M, Lousas M, Wu L, <\/strong>Arevalo JF, Pacheco KD, Johnson T, Farah ME, Rodriguez FJ, Maia M. Intravitreal Dexamethasone Implant Migration in the Anterior Chamber: A Multicenter Study from the Pan-American Collaborative Retina Study Group. Retina 2019 Feb 14. doi: 10.1097\/IAE.0000000000002475. [Epub ahead of print]<\/li>
  14. Salcedo H, Arciniegas D, Mayorga M, Wu L<\/strong>. The Role of the Water-Drinking Test in Medically Treated Open Angle Glaucoma Patients. J Fr Opthalmol 2018;41:421-424.<\/li>
  15. Hanumunthadu D, van Dijk E, Gangakhedkar S, Goud A, Cheung GCM, Cherfan D, Sarvaiya C, Meyerle C, Boon C, Singh S, Wu L, <\/strong>Chhablani J. Gender Variation in Central Serous Chorioretinopathy. Eye 2018;32:1703-1709.<\/li>
  16. Mansour AM, Foster RE, Gallego-Pinazo R, Moschos MM, Sisk RA, Chhablani J, Rojanaporn D, Sujirakul T, Arevalo JF, Lima LH, Wu L<\/strong>, Charbaji A, Saatci AO, Mansour HA, Martinez-Rubio C, Patel Y, Gangakhedkar S. Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Exudative Retinal Arterial Macroaneurysms. Retina 2018; Mar 2. doi: 10.1097\/IAE.0000000000002131. [Epub ahead of print]<\/li>
  17. Carrillo-Galvan L, Rios N, Lansingh VC, Lee A, Wu L<\/strong>, Lopez E. Analysis of Ophthalmological and Vision Related Publications in Latin America. Arq Bras Oftalmol 2018;81;24-29.<\/li>
  18. Mansour AM, Chhablani J, Arevalo JF, Wu L<\/strong>, Sharma R, Sinawat S, Sujirakul T, Assi A, V\u00e9lez-V\u00e1zquez WM, Mansour MA, Kayikcioglu O, Kucukerdonmez C, Kal A. Retinal Detachment in Albinism. Clinical Ophthalmol 2018;12:1-6<\/li>
  19. Roca JA, Wu L<\/strong>, Fromow-Guerra J, Rodriguez FJ, Berrocal MH, Rojas S, Lima LH, Gallego-Pinazo R, Chhablani J, Arevalo JF, Lozano-Rechy D, Serrano M. Yellow (577 nm) Micropulse Laser vs Half Dose Verteporfin Photodynamic Therapy in Eyes with Chronic Central Serous Chorioretinopathy: Results of the Pan American Collaborative Retina Study (PACORES) Group. Br J Ophthalmol 2018;102:1696-1700<\/li>
  20. Huang S, Wu L. Retinal Vascular Diseases in the Asia Pacific: Shifting Paradigms for Management. Asia Pac J Ophthalmol 2018;7:1-2<\/li>
  21. Acon D, Wu L<\/strong>. Multimodal Imaging in Diabetic Macular Edema. Asia Pac J Ophthalmol 2018;7:22-27<\/li>
  22. Diaz-Valverde A, Wu L<\/strong>. To Peel or Not to Peel the Internal Limiting Membrane in Idiopathic Epiretinal Membranes. Retina 2018;38:S5-S11<\/li>
  23. Schlottmann PG, Alezzandrini AA, Zas M, Rodriguez FJ, Luna JD, Wu L. <\/strong>New Treatment Modalities for Neovascular Age-Related Macular Degeneration. Asia Pac J Ophthalmol 2017;6:514-519.<\/li>
  24. Chhablani J, Paulose RM, Lasave AF, Wu L<\/strong>, Carpentier C, Maia M, Lujan S, Rojas S, Serrano M, Berrocal MH, Arevalo JF. Intravitreal bevacizumab monotherapy in myopic choroidal neovascularization: 5 year outcomes for the Pan American Collaborative Retina Study Group. Br J Ophthalmol 2018;102:455-459<\/li>
  25. Roca JA, Wu L<\/strong>, Berrocal M, Rodriguez F, Alezzandrini A, Alvira G, Velez-Montoya R, Quiroz-Mercado H, Fernando Arevalo J, Serrano M, Lima LH, Figueroa M, Farah M, Chico G. Un-Explained visual loss following silicone oil removal. Results of the Pan American Collaborative Retina Study (PACORES) Group. Int J Retina Vitreous 2017 2017 Jul 24;3:26. doi: 10.1186\/s40942-017-0079-6. eCollection 2017.<\/li>
  26. Pagano C, Wu M, Wu L<\/strong>. Acute Visual Loss and Intraretinal Hemorrhages Associated to Energy Drink Consumption. Int Ophthalmol 2017;37:1349-1351<\/li>
  27. Novais E, Maia M, Mello PA, Dias J, Garcia JM, Andrade G, Louzada R, \u00c1vila MP, Maia A, Arevalo JF, Wu L<\/strong>, Berrocal MH, Badar\u00f3 E and Farah ME. Twelve-month follow-up of dexamethasone implants for macular edema from various diseases in vitrectomized and non-vitrectomized eyes. J Ophthalmol 2016 2016:7984576. Epub 2016 Sep 18.<\/li>
  28. Chhablani J, Ambiya V, Yogi R, Li A, Shah S, Sarvaiya C, Mehta P, Meyerele C, Wu L,<\/strong> Singh R, Banker A. Subfoveal Choroidal Thickness as a Predictor of Central Serous Chorioretinopathy. Eye 2016;30:1623-1629.<\/li>
  29. Arevalo JF, Lasave A, Wu L<\/strong>, Maia M, Diaz-Llopis M, Alezandrini AA, Brito M. Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy: Results from the Pan American Collaborative Retina Study Group. Retina 2017;37:334-343.<\/li>
  30. Wu L,<\/strong> Zas M, Berrocal MH, Arevalo JF, Figueroa M, Rodriguez F, Serrano M, Graue F, Alezzandrini A, Gallego-Pinazo R, Roca JA, Iglicki M, Dalma-Weishauz J, Kozak I, Collado A, Badal J, Maia M, Salcedo-Villanueva G, Quiroz-Mercado H, Fromow-Guerra J, Lozano-Rechy D, Avila M, Chhablani J. Anatomical and Functional Outcomes of Symptomatic Idiopathic Vitreomacular Traction: A Natural History Study from the Pan American Collaborative Retina Study Group. Retina 2016;36:1913-1918.<\/li>
  31. Arevalo JF, Lasave AF, Wu L,<\/strong> Acon D, Farah ME, Gallego-Pinazo R, Alezzandrini AA, Fortuna V, Quiroz-Mercado H, Salcedo-Villanueva G, Maia M, Serrano M, Rojas S. Intravitreal Bevacizumab for Diabetic Macular Oedema: 5 Year Results of the Pan American Collaborative Retina Study Group. Br J Ophthalmol 2016;100:1605-1610<\/li>
  32. Arevalo JF, Lasave AF, Wu L,<\/strong> Acon D, Berrocal MH, Diaz-Llopis M, Gallego-Pinazo R, Serrano MA, Alezzandrini AA, Rojas S, Maia M, Lujan S. Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration: 5 Year Results of the Pan American Collaborative Retina Study Group. Retina 2016;36:859-867.<\/li>
  33. Navarro R, Machado L, Maia Jr O, Wu L<\/strong>, Farah ME, Magalhaes Jr O, Arevalo JF, Maia M. Small-Gauge Pars Plana Vitrectomy for the Management of Symptomatic Posterior Vitreous Detachment After Phacoemulsification and Multifocal Intraocular Lens Implantation: A Pilot Study From the Pan Amaerican Collaborative Retina Study Group (PACORES). J Ophthalmol 2015;156910<\/li>
  34. Chhablani J, Kozak I, Pichi F, Chenworth M, Berrocal MH, Rumneek B, Singh RP, Wu L<\/strong>, Meyerle C, Casella AM, Mansour A, Bashshur Z, Scorza A, Carral P, Nucci P, Arevalo JF. Outcomes of Treatment of Choroidal Neovascularization Associated with
    Central Serous Chorioretinopathy with Intravitreal Anti-Angiogenic
    Retina 2015;35:2489-2497.<\/li>
  35. Wu L<\/strong>. When is Macular Edema Not Macular Edema? An Update on Macular Telangiectasia Type 2. Taiwan J Ophthalmol 2015;5:149-155.<\/li>
  36. Wu L<\/strong>. Multimodality Imaging in Macular Telangiectasia 2: A Clue to Its Pathogenesis. Ind J Ophthalmol 2015;63:394-398.<\/li>
  37. Gallego-Pinazo R, Dolz-Marco R, Berrocal M, Wu L<\/strong>, Maia M, Serrano M, Alezzandrini A, Ar\u00e9valo JF, D\u00edaz-Llopis M. Outcome of diabetic patients: Results of the Pan American Collaborative Retina Study Group. Arq Bras Oftalmol 2014;77:355-359<\/li>
  38. Pascual-Camps I, Hern\u00e1ndez-Mart\u00ednez P, Monje-Fern\u00e1ndez L, Dolz-Marco R, Gallego-Pinazo R, Wu L<\/strong>, Ar\u00e9valo JF, D\u00edaz-Llopis M. Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders.<\/a> J Ophthalmic Inflamm Infect. 2014 Oct 15;4:26. doi: 10.1186\/s12348-014-0026-8<\/li>
  39. Caiado RR, Magalh\u00e3es O Jr, Badar\u00f3 E, Maia A, Novais EA, Stefanini FR, Navarro RM, Arevalo JF, Wu L<\/strong>, Moraes N, Farah ME, Maia M. Effect of Lens Status in the Surgical Success of 23 Gauge Primary Vitrectomy for the Management of Rhegmatogenous Retinal Detachment: the Pan American Collaborative Retina Study (PACORES) Group Results. Retina 2015;35:326-333<\/li>
  40. Hernandez F, Alpizar-Alvarez N, Wu L<\/strong>. Chromovitrectomy: An Update. J Ophthalmic Vis Res 2014;9:1-9.<\/li>
  41. Chhablani J, Wu L<\/strong>. Update on Choroidal Vascular Imaging Using Optical Coherence Tomography. Exp Rev Ophthalmol 2014;9:297-304.<\/li>
  42. Wu L<\/strong>, Berrocal MH, Rodriguez FJ, Maia M, Morales-Canton V, Figueroa M, Serrano M, Roca JA, Arevalo JF, Navarro R, Hernandez H, Salinas S, Romero R, Alpizar-Alvarez N, Chico G. Intraocular Pressure Elevation Following Uncomplicated Pars Plana Vitrectomy. Results of the Pan American Collaborative Retina Study Group. Retina 2014;34:1985-1989.<\/li>
  43. Gallego-Pinazo R, Hernandez-Martinez P, Herv\u00e1s-Ontiveros A, Martinez-Castillo S, Dolz-Marco R, Arevalo JF, Wu L<\/strong>, Diaz-Llopis M. Local Safety Concerns of Repeated Dexamethasone Intravitreal Implant (Ozurdex) for Macular Diseases. J Ocul Diseases Therapeutics 2013;1:10-14.<\/li>
  44. Wu L<\/strong>, Fernandez-Loaiza P, Sauma J, Hernandez-Bogantes E, Masis M. Classification of Diabetic Retinopathy and Diabetic Macular Edema. World Journal of Diabetes 2013;4:290-294.<\/li>
  45. Figueroa MS, Contreras I, Noval S, PACORES Study Group. Anatomic and Visual Outcomes of 23-G Vitrectomy Without Scleral Buckling for Primary Rhegmatogenous Retinal Detachment. Eur J Ophthalmol 2013;23:417-422<\/li>
  46. Wu L<\/strong>, Alpizar-Alvarez N. Choroidal Imaging by Spectral Domain Optical Coherence Tomography. Taiwan J Ophthalmol 2013;3:3-13.<\/li>
  47. Carpentier C, Zanolli M, Wu L<\/strong>, Sepulveda G, Berrocal MH, Saravia M, Diaz-Llopis M, Gallego-Pinazo R, Filsecker L, Verdaguer-Diaz JI, Milan Navarro R, Arevalo JF, Maia M. Residual ILM\u00a0Following ERM Peeling: Results of the Pan American Collaborative Retina Study Group. Retina 2013;33:2026-2031.<\/li>
  48. Wu L<\/strong>. Is Tissue Necrosis Factor Alpha an Important Target in Age-Related Macular Degeneration and Diabetic Macular Edema? Retina 2013;33:1287-1290.<\/li>
  49. Arevalo JF, Serrano M, Wu L<\/strong>. Combined Inhibition of Tumor Necrosis Factor (TNF) and Vascular Endothelial Growth Factor (VEGF) for the treatment of Macular Edema of Various Etiologies: A Short Term Pilot Study. Eye (Lond). 2013;27:569-571.<\/li>
  50. Wu L,<\/strong> Evans T, Arevalo JF. Idiopathic Macular Telangiectasia Type 2 (Idiopathic Juxtafoveolar Retinal Telangiectasis Type 2A).\u00a0 Survey Ophthalmol DOI:10.1016\/j.survophthal.2012.11.007<\/li>
  51. Arevalo JF<\/a>,\u00a0Lasave AF<\/u><\/a>,\u00a0Wu L<\/u><\/a><\/strong>,\u00a0Diaz-Llopis M<\/u><\/a>,\u00a0Gallego-Pinazo R<\/u><\/a>,\u00a0Alezzandrini AA<\/u><\/a>,\u00a0Berrocal MH<\/u><\/a>. Intravitreal Bevacizumab Plus Grid Laser Photocoagulation or Intravitreal Bevacizumab or Grid Laser Photocoagulation for Diffuse Diabetic Macular Edema: Results of the Pan American Collaborative Retina Study Group at 24 Months. Retina 2012\u00a0 Dec 5 epub ahead of print.<\/li>
  52. Wu L<\/strong>, Arevalo JF, Hernandez-Bogantes E, Regatieri C, Farah ME, Roca JA. Intravitreal TNF-Alpha Inhibitors for Neovascular AMD Sub-Optimally Responsive to Anti-VEGF Agents: A Pilot Study from the Pan American Collaborative Retina Study Group. J Ocular Pharmacol Therapeutics.\u00a0 In Press<\/li>
  53. Wu L<\/strong>, Hernandez-Bogantes E, Roca JA, Arevalo JF. Reply Retina 2012;32:2179-2180.<\/li>
  54. Wu L<\/strong>, Arevalo JF, Hernandez-Bogantes E, Roca JA. Intravitreal Infliximab for Refractory Pseudo-phakic Cystoid Macular Edema: Results of the Pan American Collaborative Retina Study Group. Int Ophthalmol 2012;32:235-243.<\/li>
  55. Arevalo JF, Sanchez JG, Saldarriaga L, Berrocal MH, Fromow-Guerra J, Morales-Canton V, Wu L<\/strong>, Maia M, Saravia MJ, Bare\u00f1o J. Retinal Detachment After Bevacizumab. Ophthalmology 2011;118:2304.e3-7<\/li>
  56. Arevalo JF, Sanchez JG, Lasave AF, Wu L<\/strong>, Maia M, Bonafonte S, Brito M, Alezzandrini AA, Restrepo N, Berrocal MH, Saravia M, Farah ME, Fromow-Guerra J, Morales-Canton V. Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture. J Ophthalmol 2011;2011:584238.<\/li>
  57. Martinez J, Hernandez-Bogantes E, Wu L<\/strong>. Diabetic Retinopathy Screening with Single Field Digital Fundus Photography at a District Level in Costa Rica: A Pilot Study. \u00a0Int Ophthalmol 2011;31:83-88.\u00a0<\/li>
  58. Wu L<\/strong>, Berrocal MH, Arevalo JF, Carpentier C, et al. Endophthalmitis Post Pars Plana Vitrectomy: Results of the Pan American Collaborative Retina Study Group.\u00a0 Retina 2011;31:673-678.<\/li>
  59. Arevalo JF, Adan A, Berrocal MH, Espinoza JV, Maia M, Wu L<\/strong>, Roca JA, Quiroz-Mercado H, Ruiz-Moreno JM, Serrano MA.\u00a0 Intravitreal Bevacizumab for Inflammatory Choroidal Neovascularization: Results from the Pan American Collaborative Retina Study Group at 24 Months.\u00a0 Retina 2011;31:353-363<\/li>
  60. Wu L<\/strong>, Evans T. Immediate Changes in Intraocular Pressure After an Intravitreal Injection of 2.5 mg of Bevacizumab. Arch Soc Esp Oftalmol 2010;85:364-369.<\/li>
  61. Penha FM, Maia M, Cardillo JA, Arevalo JF, Wu L<\/strong>, Rodriguez FJ, Berrocal MH, Farah ME. Comparison of a Single Intravitreal Injection of Bevacizumab vs Triamcinolone Acetonide as Primary Treatment for Diffuse Diabetic Macular Oedema. Acta Ophthalmol 2012;90:e160-161.<\/li>
  62. Wu L<\/strong>, Evans T. An Intravenous Microdose of Bevacizumab \u00a0for the Treatment of Pigment Epithelial Detachment Associated to Age-Related Macular Degeneration Refractory to Intravitreal Bevacizumab: A Case Report. Retinal Cases and Brief Reports. doi: 10.1097\/ICB.0b013e3181f66d28<\/li>
  63. Arevalo JF, Sanchez JG, Lasave AF, Wu L<\/strong>, Maia M, Bonafonte S, Brito M, Alezzandrini AA, Restrepo N, Berrocal MH, Saravia M, Farah ME, Fromow-Guerra J, Morales-Canton V. Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy at 24 Months: The 2008 Juan Verdaguer-Planas Lecture. Curr Diabetes Rev 2010;6:313-322<\/li>
  64. Arevalo JF, Sanchez JG, Wu L<\/strong>, Berrocal MH, Alezzandrini AA, Restrepo N, Maia M, Farah ME, Brito M, Diaz-Llopis M, Rodriguez FJ, Reategui G, Iturralde-Iraola J, Udaondo-Mirete P. Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration at 24 Months: The Pan American Collaborative Retina Study Group. Ophthalmology 2010;117:1974-1981.<\/li>
  65. Wu L<\/strong>, Hernandez-Bogantes E, Roca JA, Arevalo JF, Barraza K, Lasave A. Intravitreal TNF Inhibitors in the Treatment of Refractory Diabetic Macular Edema: A pilot Study from the Pan American Collaborative Retina Study Group. Retina 2011;31:298-303<\/li>
  66. Wu L<\/strong>, Arevalo JF, Berrocal MH, Maia M, Roca JA, Morales-Canton V, Alezzandrini AA, Diaz-Llopis MJ. Comparison of Two Doses of Intravitreal Bevacizumab as Primary Treatment for Macular Edema Secondary to Central Retinal Vein Occlusions: Results of the Pan American Collaborative Retina Study Group at 24 Months.\u00a0 Retina 2010;30:1002-1011.<\/li>
  67. Wu L<\/strong>, Arevalo JF, Berrocal MH, Maia M, Roca JA, Morales-Canton V, Alezzandrini AA, Diaz-Llopis MJ. Comparison of Two Doses of Intravitreal Bevacizumab as Primary Treatment for Macular Edema Secondary to Branch Retinal Vein Occlusions: Results of the Pan American Collaborative Retina Study Group at 24 Months. Retina 2009;29(10):1396-1403.<\/li>
  68. Arevalo JF, Maia M, Garcia-Amaris RA, Roca JA, Sanchez JG, Berrocal MH, Wu L. <\/strong>Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema: The Pan American Collaborative Retina Study Group Results. Ophthalmology 2009;116(8):1481-1487.e1<\/li>
  69. Arevalo JF, Sanchez JG, Wu L, <\/strong>Maia M, Alezzandrini AA, Brito M, Bonafonte S, Lujan S, Diaz-Llopis M, Restrepo N, Rodriguez FJ, Udaondo-Mirete P. Primary Intravitreal Bevacizumab for Diffuse Macular Edema: The Pan American Collaborative Retina Study Group at 24 Months. Ophthalmology 2009;116(8):1488-1497.e1.<\/li>
  70. Arevalo JF, Sanchez JG, Fromow-Guerra J, Wu L<\/strong>, Berrocal MH, Farah ME, Cardillo J, Rodriguez FJ. Comparison of 2 Doses of\u00a0 Primary Intravitreal Bevacizumab (Avastin) for Diffuse Diabetic Macular Edema: Results from the Pan American Collaborative Retina Study Group (PACORES) at 12 Months Follow-Up. Graefes Arch Clin Exp Ophthalmol 2009;247(6):735-743.<\/li>
  71. Cohen D, Rambeloarisoa, Florea L, Leye YM, Deplus S, Gaudric A, Farge-Bancel D, Wu L<\/strong>, Davis J. Diagnostic and Therapeutic Challenges. Retina 2009;29:117-120<\/li>
  72. Arevalo JF, Wu L<\/strong>, Sanchez JG, Maia M, Saravia M, Fernandez CF, Evans T. Intravitreal bevacizumab (Avastin) for Proliferative Diabetic Retinopathy: 6 months follow-up. Eye 2009;23:117-123<\/li>
  73. Wu L<\/strong>, Arevalo JF, Maia M, Berrocal MH, Sanchez J, Evans T. Comparing Outcomes in Patients with Subfovel Choroidal Neovascularization Secondary to Age-Related Macular Degeneration Treated with Two Different Doses of Primary Intravitreal Bevacizumab: Results of the Pan-American Collaborative Retina Study Group (PACORES) at the 12-Month Follow-up. Jap J Ophthalmol 2009;53(2):125-130.<\/li>
  74. Wu L<\/strong>, Evan T, Saravia M, Schlaen A, Couto C. Intravitreal bevacizumab for choroidal neovascularization secondary to the Vogt Koyanagi Harada Syndrome. Jap J Ophthalmol 2009;53(1):57-60.<\/li>
  75. Wu L, <\/strong>Tapia-Herrera G. <\/strong>Fungal Endophthalmitis. Current Fungal Infections Reports 2009;3:55-61.<\/li>
  76. Arevalo JF, Garcia RA, Wu L<\/strong>, Rodriguez FJ, Dalma-Weishauz J, Quiroz-Mercado H, Morales-Canton V, Roca JA, Berrocal MH, Graue-Wiechers F, Robledo V. Radial Optic Neurotomy. Results of the Pan American Collaborative Retina Study Group (PACORES). Retina 2008;28(8):1044-1052<\/li>
  77. Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, <\/strong>Saravia M, Costa RA. Primary Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration: Results of the Pan-American Collaborative Retina Study Group at 12-months Follow-up. Retina 2008;28(10):1387-1394.<\/li>
  78. Wu L<\/strong>, Arevalo JF, Roca JA, Maia M, Berrocal MH, Rodrihuez FJ, Evans T, Costa RA, Cardillo J. Comparison of 2 Doses of Intravitreal Bevacizumab (Avastin\u00ae) for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: Results from the Pan-American Collaborative Retina Study Group at 6-Month Follow-Up. Retina 2008;28:212-219.<\/em>\u00a0<\/em><\/li>
  79. Arevalo JF, Maia M, Flynn HW Jr, Saravia M, Avery RL, Wu L<\/strong>, Farah ME, Pieramici DJ, Berrocal MH, Sanchez JG. Tractional Retinal Detachment following Intravitreal Bevacizumab (Avastin\u00ae) in patients with Severe Proliferative Diabetic Retinopathy. Br J Ophthalmol 2008;92:213-216.<\/li>
  80. Wu L<\/strong>, Martinez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, Maia M, Roca JA, Rodriguez FJ. Twelve month Safety of Intravitreal Injections of Bevacizumab (Avastin): Results of the Pan American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 2008;246:81-87<\/li>
  81. Wu L<\/strong>, Evans T. Arevalo JF, Rodriguez FJ, Berrocal MH, Hsu M. Long Term Effect of Intravitreal Triamcinolone in the Nonproliferative Stage of Type II Idiopathic Parafoveal Telangiectasia. Retina 2008;28:314-319.<\/li>
  82. Wu L<\/strong>, Velasquez R, Montoya O. Non-Infectious Endophthalmitis Associated with Trypan Blue Use in Cataract Surgery. International Ophthalmology 2008;28:89-93.<\/li>
  83. Arevalo JF, Garcia-Amaris RA, Roca JA, Sanchez JG, Wu L<\/strong>, Berrocal MH, Maia M. Primary Intravitreal Bevacizumab (Avastin) for the Management of Pseudophakic Cystoid Macular Edema: A Pilot Study from the Pan-American Collaborative Retina Study Group. J Cataract Refractive Surgery 2007;33:2098-2105.<\/li>
  84. Sanchez JG, Garcia RA, Wu L,<\/strong> Berrocal MH, Graue-Wiechers F, Rodriguez FJ, Robledo V, Lizana C, Pikulich Z, Mendoza AJ, Velez-Vasquez W, Arevalo JF. Optical Coherence Tomography Characterisitics of Group 2A Idiopathic Parafoveal Telangiectasis. Retina 2007;27:1214-1220.<\/li>
  85. Arevalo JF, Sanchez JG, Garcia RA, Wu L<\/strong>, Berrocal MH, Rodriguez FJ, Rodriguez A, Novoa LA, Garcia-Amaris R. Indocyanine green mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.\u00a0 Graefes Arch Clin Exp Ophthalmol 2007;245:1673-1680.<\/li>
  86. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L<\/strong>, Maia M,Berrocal MH, Solis-Vivanco A, Farah ME, Rodriguez FJ. Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema: Results of the Pan-American Collaborative Retina Study Group at 6-months Follow-up. Ophthalmology 2007;114:743-750.<\/li>
  87. Wu L<\/strong>, Evans T, Tapia-Herrera G. The XXVII Pan American Congress of Ophthalmology. Expert Rev Ophthalmol 2007;2:533-534.<\/li>
  88. Wu L<\/strong>, Calder\u00f3n M, Marbis J, Hernandez, G, Ramirez V. Bilateral Exudative Retinal Detachment as the First Sign of Relapsing Acute Myelogenous Leukemia. Clin Exp Ophthalmol 2006;34(6):623-625<\/li>
  89. Wu L<\/strong>, Flikier D. Corneal Graft Dehiscense During Pneumatic Retinopexy. Retina 2006;26(6):707.<\/li>
  90. Wu L<\/strong>, Murphy RP. Photodynamic therapy in choroidal neovascularization.\u00a0 Curr Opin Ophthalmol. 1999;10:217-220.<\/li>
  91. Maxwell DP, Brent BD, Diamond JG and Wu L<\/strong>. Effect of intravitreal dexamethasone on ocular histopathology in a rabbit model of endophthalmitis.\u00a0 Ophthalmology 1991; 98: 1370-1375.<\/li>
  92. Baricos WH, Cortez SL, Le QC, Wu L<\/strong>, Shaw E, Hanada K, Shah SV. Evidence suggesting a role for Cathepsin L in an experimental model of glomerulonephritis. Arch Biochem Biophys 1991;288(2):468-472.<\/li>
  93. Baricos WH, O\u2019Connor SE, Cortez S, Wu L<\/strong> and Shah SV. The cysteine proteinase inhibitor, E-64, reduces proteinuria in an experimental model of glomerulonephritis.\u00a0 Biochem Biophys Res Comm 1988; 155: 1318-1323.<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    <\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

    Publicaciones Wu L. The Omnipresence of Vascular Endothelial Growth Factor in Retinal Diseases. Taiwan J Ophthalmol 2019;9:213-215. Wu L, Acon D, Wu A, Wu M. Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm? Taiwan J Ophthalmol 2019;9:216-223 Flikier S, Wu A, Wu L. Revisiting Pars Plana Vitrectomy in the Primary …<\/p>\n

    PUBLICATIONS<\/span> Read More »<\/a><\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-300","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/retinacr.com\/en\/wp-json\/wp\/v2\/pages\/300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/retinacr.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/retinacr.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/retinacr.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/retinacr.com\/en\/wp-json\/wp\/v2\/comments?post=300"}],"version-history":[{"count":4,"href":"https:\/\/retinacr.com\/en\/wp-json\/wp\/v2\/pages\/300\/revisions"}],"predecessor-version":[{"id":328,"href":"https:\/\/retinacr.com\/en\/wp-json\/wp\/v2\/pages\/300\/revisions\/328"}],"wp:attachment":[{"href":"https:\/\/retinacr.com\/en\/wp-json\/wp\/v2\/media?parent=300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}